#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma pancreas Glioma Adrenogenital syndrome Astrocytoma malignant Atypical haemolytic uraemic syndrome Autoimmune demyelinating disease Squamous cell carcinoma of the cervix Anti-neutrophil cytoplasmic antibody positive vasculitis Small intestine neuroendocrine tumour Retinoblastoma Immune-mediated myositis Hypersomnia Wiskott-Aldrich syndrome Leukaemia NTRK gene fusion overexpression More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Treatment Ewing’s sarcoma – Trials in Disease Burkitt’s lymphoma – Trials in Disease Synovial sarcoma metastatic – Life with Disease Optic glioma – Basic Information Nephroblastoma – Diagnostics Haemophilia B with anti factor IX – Diagnostics Medulloblastoma – Life with Disease Antithrombin III deficiency – Diagnostics Chondrosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AGANIRSEN Piperacillin Monohydrate Dexamethasone Isonicotinate Blu-451 Cocarboxylase Tetrahydrate Gfh925 Tusamitamab Ravtansine Tapderimotide Gemcitabine Hydrochloride Paroxetine Hydrochloride Modafinil Tezacaftor Milrinone GSK4418959A IHMA-2121771-1 Sodium Oxybate Anhydrous Benzoyl Peroxide Axitinib ATIRMOCICLIB Bupivacaine Hydrochloride More therapies…

    Learn about Your Condition

    Immunodeficiency congenital Cardiac arrest Ocular lymphoma Cardiovascular disorder Intestinal obstruction Urinary incontinence Atrial flutter Leiomyosarcoma Eosinophilic oesophagitis Alcoholic liver disease Retinoblastoma Gastrooesophageal cancer Still's disease Guttate psoriasis Vaginal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Platelet Concentrate for Treating Tennis Elbow in Patients: Comparing Surgery and Injection Methods

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Epicondylitis
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study on Antibiotic Treatment for Uncomplicated Acute Appendicitis Using Levofloxacin, Ertapenem, and Moxifloxacin in Adult Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Ertapenem
    • Levofloxacin
    • Metronidazole
    Finland

  • Study on the Effectiveness of Fluorouracil, Levoleucovorin, and Oxaliplatin in Patients with Resected Small Bowel Adenocarcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Levoleucovorin
    Belgium

  • Study on the Effects of Opioid-Free Anesthesia with Ketamine Hydrochloride on Oxygen Levels in Patients Undergoing Bariatric Surgery

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Ketamine Hydrochloride
    Spain

  • Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Atezolizumab
    • Pertuzumab
    • Trastuzumab
    Austria Belgium Germany Italy Romania Spain

  • Study on Sirolimus for Treating Cervico-facial Lymphatic Malformations in Patients with Poor Prognosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphatic malformation
    Investigated Drugs:
    • Sirolimus
    France
Previous Page
1 … 851 852 853 854 855 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!